Cargando…
Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase
Scalable isogenic models of cancer-associated mutations are critical to studying dysregulated gene function. Nonsynonymous mutations of splicing factors, which typically affect one allele, are common in many cancers, but paradoxically confer growth disadvantage to cell lines, making their generation...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514589/ https://www.ncbi.nlm.nih.gov/pubmed/34645977 http://dx.doi.org/10.1038/s42003-021-02690-1 |
_version_ | 1784583423823708160 |
---|---|
author | Boddu, Prajwal C. Gupta, Abhishek K. Kim, Jung-Sik Neugebauer, Karla M. Waldman, Todd Pillai, Manoj M. |
author_facet | Boddu, Prajwal C. Gupta, Abhishek K. Kim, Jung-Sik Neugebauer, Karla M. Waldman, Todd Pillai, Manoj M. |
author_sort | Boddu, Prajwal C. |
collection | PubMed |
description | Scalable isogenic models of cancer-associated mutations are critical to studying dysregulated gene function. Nonsynonymous mutations of splicing factors, which typically affect one allele, are common in many cancers, but paradoxically confer growth disadvantage to cell lines, making their generation and expansion challenging. Here, we combine AAV-intron trap, CRISPR/Cas9, and inducible Cre-recombinase systems to achieve >90% efficiency to introduce the oncogenic K700E mutation in SF3B1, a splicing factor commonly mutated in multiple cancers. The intron-trap design of AAV vector limits editing to one allele. CRISPR/Cas9-induced double stranded DNA breaks direct homologous recombination to the desired genomic locus. Inducible Cre-recombinase allows for the expansion of cells prior to loxp excision and expression of the mutant allele. Importantly, AAV or CRISPR/Cas9 alone results in much lower editing efficiency and the edited cells do not expand due to toxicity of SF3B1-K700E. Our approach can be readily adapted to generate scalable isogenic systems where mutant oncogenes confer a growth disadvantage. |
format | Online Article Text |
id | pubmed-8514589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85145892021-10-29 Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase Boddu, Prajwal C. Gupta, Abhishek K. Kim, Jung-Sik Neugebauer, Karla M. Waldman, Todd Pillai, Manoj M. Commun Biol Article Scalable isogenic models of cancer-associated mutations are critical to studying dysregulated gene function. Nonsynonymous mutations of splicing factors, which typically affect one allele, are common in many cancers, but paradoxically confer growth disadvantage to cell lines, making their generation and expansion challenging. Here, we combine AAV-intron trap, CRISPR/Cas9, and inducible Cre-recombinase systems to achieve >90% efficiency to introduce the oncogenic K700E mutation in SF3B1, a splicing factor commonly mutated in multiple cancers. The intron-trap design of AAV vector limits editing to one allele. CRISPR/Cas9-induced double stranded DNA breaks direct homologous recombination to the desired genomic locus. Inducible Cre-recombinase allows for the expansion of cells prior to loxp excision and expression of the mutant allele. Importantly, AAV or CRISPR/Cas9 alone results in much lower editing efficiency and the edited cells do not expand due to toxicity of SF3B1-K700E. Our approach can be readily adapted to generate scalable isogenic systems where mutant oncogenes confer a growth disadvantage. Nature Publishing Group UK 2021-10-13 /pmc/articles/PMC8514589/ /pubmed/34645977 http://dx.doi.org/10.1038/s42003-021-02690-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Boddu, Prajwal C. Gupta, Abhishek K. Kim, Jung-Sik Neugebauer, Karla M. Waldman, Todd Pillai, Manoj M. Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase |
title | Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase |
title_full | Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase |
title_fullStr | Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase |
title_full_unstemmed | Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase |
title_short | Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase |
title_sort | generation of scalable cancer models by combining aav-intron-trap, crispr/cas9, and inducible cre-recombinase |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514589/ https://www.ncbi.nlm.nih.gov/pubmed/34645977 http://dx.doi.org/10.1038/s42003-021-02690-1 |
work_keys_str_mv | AT bodduprajwalc generationofscalablecancermodelsbycombiningaavintrontrapcrisprcas9andinduciblecrerecombinase AT guptaabhishekk generationofscalablecancermodelsbycombiningaavintrontrapcrisprcas9andinduciblecrerecombinase AT kimjungsik generationofscalablecancermodelsbycombiningaavintrontrapcrisprcas9andinduciblecrerecombinase AT neugebauerkarlam generationofscalablecancermodelsbycombiningaavintrontrapcrisprcas9andinduciblecrerecombinase AT waldmantodd generationofscalablecancermodelsbycombiningaavintrontrapcrisprcas9andinduciblecrerecombinase AT pillaimanojm generationofscalablecancermodelsbycombiningaavintrontrapcrisprcas9andinduciblecrerecombinase |